Skip to content

Dietary Management of Gestational Diabetes Mellitus

Dietary Management of Gestational Diabetes Mellitus

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05613920
Enrollment
48
Registered
2022-11-14
Start date
2022-11-10
Completion date
2023-02-28
Last updated
2022-11-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diet, Gestational Diabetes Mellitus in Pregnancy, Healthy

Brief summary

The goal of this clinical trial is to test effect of dietary management program based on the nudge strategy in gestational diabetes mellitus patients. The main questions it aims to answer is whether the dietary management program is effective for the diet management behavior of gestational diabetes mellitus patients. Participants will receive a 12 week dietary management program. The intervention group will receive a diet management program based on the nudge strategy, and the control group will receive a routine dietary management program. Researchers will compare two group's glycemic control and pregnancy outcomes and to see if effective for the diet management behavior.

Interventions

BEHAVIORALdiet management program based on the nudge strategy

The intervention group received a 12-week dietary management intervention based on the nudge strategy. The MINDSPACE framework was used, which has nine intervention categories. Face-to-face intervention and telephone follow-up were used to provide targeted dietary management.

Sponsors

Qingdao University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

1. Meeting the diagnostic criteria related to GDM by oral glucose tolerance test (OGTT), etc. 2. Singleton pregnancy 3. Age ≥ 18 years 4. Gestational weeks 24-28 5. Informed consent for voluntary participation in this study

Exclusion criteria

1.Patients with significant heart, liver, lung and other organ failure and malignancy 2.Previous history of psychiatric disorders or existing psychiatric disorders 3.Diabetes combined with other complications such as gestational hypertension Dropout criteria 1. Lost to the study due to unforeseen circumstances 2. Voluntarily requested to withdraw from the study 3. Did not take the intervention as required by the relevant requirements 4. Condition was unstable and could not continue to cooperate.

Design outcomes

Primary

MeasureTime frameDescription
Changes in blood glucose levels over timePre-intervention, 1-month post-intervention and 3-months post-interventionWith the change of intervention and time, it is better for the fasting blood glucose to decrease; With the change of intervention and time, it is better that the 1hPG decreases; With the change of intervention and time, it is better that the 2hPG decreases.

Secondary

MeasureTime frameDescription
pregnancy outcomesDuring the delivery of pregnant women, the relevant data of pregnancy outcome were collected by consulting medical records or telephone follow-up.Number of Participants with Premature, Cesarean delivery, Gestational hypertension, Giant baby, Fetal intrauterine distress

Other

MeasureTime frameDescription
Apgar score of newbornApgar score at 1 minute and 5 minutes after birthApgar score at 1 minute and 5 minutes after birth in both groups

Countries

China

Contacts

Primary ContactHeng Liu
hengliu@qdu.edu.cn86-0532-82991205
Backup ContactHeng Liu
hengliu516@163.com86-0532-82991205

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026